对“外用0.33%酒石酸溴莫尼定凝胶治疗玫瑰痤疮引起的变应性接触性皮炎”的回复 - Suppr

Suppr

超能文献

Reply to "Allergic contact dermatitis to topical brimonidine tartrate gel 0.33% for treatment of rosacea".

作者信息

Del Rosso James Q

机构信息

Touro University College of Osteopathic Medicine, Las Vegas, Nevada.

出版信息

J Am Acad Dermatol. 2014 Oct;71(4):833-4. doi: 10.1016/j.jaad.2014.06.040.

DOI:10.1016/j.jaad.2014.06.040

PMID:25219709

Abstract

摘要

相似文献

Reply to "Allergic contact dermatitis to topical brimonidine tartrate gel 0.33% for treatment of rosacea".

J Am Acad Dermatol. 2014 Oct;71(4):833-4. doi: 10.1016/j.jaad.2014.06.040.

Allergic contact dermatitis to topical brimonidine tartrate gel 0.33% for treatment of rosacea.

J Am Acad Dermatol. 2014 Oct;71(4):832-3. doi: 10.1016/j.jaad.2014.05.073.

Allergic contact dermatitis caused by Mirvaso®, brimonidine tartrate gel 0.33%, a new topical treatment for rosaceal erythema.

Contact Dermatitis. 2015 Dec;73(6):366-7. doi: 10.1111/cod.12476.

Sensitization to and allergic contact dermatitis caused by Mirvaso(®) (brimonidine tartrate) for treatment of rosacea - 2 cases.

Contact Dermatitis. 2016 Jun;74(6):378-9. doi: 10.1111/cod.12547.

Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study.

J Drugs Dermatol. 2014 Jan;13(1):56-61.

Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies.

J Drugs Dermatol. 2013 Jun 1;12(6):650-6.

Case Report: Allergic Contact Dermatitis to Topical Brimonidine Demonstrated With Patch Testing: Insights on Evaluation of Brimonidine Sensitization.

J Cutan Med Surg. 2018 Nov/Dec;22(6):636-638. doi: 10.1177/1203475418789020. Epub 2018 Jul 18.

Management of facial erythema of rosacea: what is the role of topical α-adrenergic receptor agonist therapy?

J Am Acad Dermatol. 2013 Dec;69(6 Suppl 1):S44-56. doi: 10.1016/j.jaad.2013.06.009.

Rosacea or photodamaged skin? Use of brimonidine gel in differentiating erythema in the two conditions.

Australas J Dermatol. 2017 Feb;58(1):63-64. doi: 10.1111/ajd.12430. Epub 2016 Jan 13.

Brimonidine tartrate for the treatment of facial flushing and erythema in rosacea.

Expert Rev Clin Pharmacol. 2014 Sep;7(5):567-77. doi: 10.1586/17512433.2014.945910. Epub 2014 Aug 4.

引用本文的文献

Topical a-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?

J Clin Aesthet Dermatol. 2017 Jul;10(7):28-32. Epub 2017 Jul 1.

The role of brimonidine tartrate gel in the treatment of rosacea.

Clin Cosmet Investig Dermatol. 2015 Oct 23;8:529-38. doi: 10.2147/CCID.S58920. eCollection 2015.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Reply to "Allergic contact dermatitis to topical brimonidine tartrate gel 0.33% for treatment of rosacea".

作者信息

Del Rosso James Q

机构信息

Touro University College of Osteopathic Medicine, Las Vegas, Nevada.

出版信息

J Am Acad Dermatol. 2014 Oct;71(4):833-4. doi: 10.1016/j.jaad.2014.06.040.

DOI:10.1016/j.jaad.2014.06.040

PMID:25219709

Abstract

摘要